CWA Asset Management Group LLC grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 1,062.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,555 shares of the company’s stock after buying an additional 8,733 shares during the quarter. CWA Asset Management Group LLC’s holdings in HCA Healthcare were worth $4,461,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Norges Bank bought a new position in HCA Healthcare in the second quarter valued at about $1,152,408,000. Pacer Advisors Inc. increased its stake in shares of HCA Healthcare by 6,115.3% in the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after buying an additional 896,437 shares during the period. Viking Global Investors LP boosted its position in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares during the period. Danske Bank A S acquired a new position in HCA Healthcare in the 3rd quarter valued at approximately $115,530,000. Finally, Zurich Insurance Group Ltd FI lifted its holdings in shares of HCA Healthcare by 3,755.9% during the third quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after purchasing an additional 262,912 shares during the period. Institutional investors own 62.73% of the company’s stock.
Insider Transactions at HCA Healthcare
In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 15,214 shares of company stock valued at $7,797,595. 1.30% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
View Our Latest Analysis on HCA Healthcare
HCA Healthcare Price Performance
NYSE HCA opened at $493.61 on Friday. The stock has a market capitalization of $110.36 billion, a P/E ratio of 17.39, a P/E/G ratio of 1.52 and a beta of 1.34. HCA Healthcare, Inc. has a one year low of $314.43 and a one year high of $556.52. The business has a 50 day simple moving average of $510.01 and a 200 day simple moving average of $473.55.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter last year, the firm posted $6.22 EPS. The company’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.99%.
HCA Healthcare News Roundup
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Jim Cramer publicly recommended buying HCA, calling it a buy in “big clumps,” which can drive retail interest and short‑term inflows. Jim Cramer on HCA Healthcare
- Positive Sentiment: HCA hospitals received regional/national recognition (Ocala hospitals praised for patient safety; HCA Florida North Florida Hospital named to America’s 250 Best Hospitals), which supports brand, referrals and patient volumes. Ocala hospitals honored for excellence in patient safety
- Positive Sentiment: HCA Florida North Florida Hospital included among America’s 250 Best Hospitals, reinforcing quality credentials that can protect pricing and payer relationships. HCA Florida North Florida Hospital among America’s 250 Best Hospitals
- Positive Sentiment: Virginia regulators approved new hospitals/expansions that include HCA projects, supporting medium‑term revenue growth and market share in that region. State approves three Chesterfield hospital projects
- Neutral Sentiment: Human-interest coverage (a North Carolina NICU St. Patrick’s Day feature) highlights community care but is unlikely to move the stock materially. North Carolina NICU Celebrates St. Patrick’s Day
- Negative Sentiment: HCA’s board urged shareholders to reject a proposal for fuller reporting on the aftermath of the 2019 Mission sale — a governance/oversight flashpoint that can raise investor concern and activist interest. HCA board urges shareholders to reject proposal
- Negative Sentiment: An HCA hospital CEO is leaving for Beth Israel Lahey Health — an executive departure that may be seen as local leadership turnover and could modestly concern investors about continuity in affected markets. HCA hospital CEO heads to Beth Israel Lahey Health
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
